The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU) and leucovorin (LV) or gemcitabine plus cisplatin in advanced cholangiocarcinoma: The AIO-NIFE-trial, an open label, randomized, multicenter phase II trial.
 
Thomas Jens Ettrich
Honoraria - Celgene
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck Serono; Merck Serono; Novartis; Novartis; Novartis; Pfizer; Sanofi; Sanofi; Sirtex Medical
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen; Ipsen
 
Andreas Wolfgang Berger
Consulting or Advisory Role - Sanofi/Aventis
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Thomas Seufferlein
Honoraria - Amgen; Bayer Schering Pharma; Celgene; Falk Foundation; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Lilly; Merck Serono
Research Funding - Celgene; Sanofi
Travel, Accommodations, Expenses - Bayer Schering Pharma; Celgene; Merck Serono; Roche; Sanofi
 
Lukas Perkhofer
No Relationships to Disclose